First professional · Philadelphia, Pennsylvania

Is Pharmacy, Pharmaceutical Sciences, and Administration at Philadelphia College of Osteopathic Medicine worth it?

High confidence High confidence: 100+ graduates behind the earnings figures.

The verdict · all families, in-state, half paid with loans

Pays back slowly: graduates typically recover the cost in about 7.4 years.

Earnings 1 year after graduating: $108,176; Treasury AY2020-21, AY2021-22 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Earnings 4 years after graduating: $137,869; Treasury AY2017-2018, AY2018-2019 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Typical federal debt at graduation: $248,266; NSLDS pooled AY2022-23, AY2023-24 cohort
Typical borrowing (no graduate net price is published): $263k (likely $263k – $263k); AcadYr 2024-25, reported in IPEDS DCY2025-26
Earnings bump, year 4: $67k a year vs bachelor's graduates 4 years out in PA; 2023 ACS 5-year pooled, adjusted to 2024 dollars
Payback: 7.4 years (likely 6.3–8.8); Bump vs net cost plus loan interest
10-year net return: −$101k (likely −$239k – $32k); Today's dollars
20-year net return: $713k (likely $417k – $1.02M); Today's dollars
Borrowers making progress / in default, 2 years in: ≤ 20% / not reported; NSLDS AY2016-17, AY2017-18 pooled cohorts measured in 2018-19, 2019-20

Scorecard reports no net price for graduate programs; cost is based on what graduates typically borrowed.